CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
Go back to CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization| (NASDAQ: CRVO) | Delayed: 3.02 +0.09 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.93 | 52 Week High | $ | |||
| Open | $2.96 | 52 Week Low | $ | |||
| Day High | $3.07 | P/E | N/A | |||
| Day Low | $2.88 | EPS | $ | |||
| Volume | 225,514 | |||||

